Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Hydrolyzed chicken cartilage** refers to the enzymatically hydrolyzed (broken down) form of cartilage derived specifically from chicken, most commonly containing collagen type II as its principal component. This supplement exists primarily as low-molecular-weight collagen peptides for improved absorption. The product has been studied for its benefits in **joint health** (reducing pain, stiffness, supporting mobility) and **skin health** (enhancing elasticity, reducing wrinkles, and supporting dermal extracellular matrix components)[1][2][4][3]. Its mechanism of action is thought to involve the stimulation of chondrocytes and dermal fibroblasts to synthesize collagen and hyaluronic acid, thereby supporting cartilage and skin function[2][3]. Clinical trials have demonstrated benefits in individuals with mild joint discomfort and aging-associated skin changes[1][2][4]. It is formulated and sold as a nutritional or dietary supplement, often under the brand "BioCell Collagen" and related products[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrolyzed chicken cartilage.